Clinical Trials in Pittsburgh

Showing 12981-13000 of 21,047 trials

Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders

NCT01866956

The KSADS-COMP will facilitate identification of comorbid psychiatric and substance use diagnoses frequently missed in clinical practice, and improve adolescent treatment outcomes. The self-administered version of the KSADS-COMP can also be used cost-effectively in schools and juvenile justice settings where there is a growing interest in early identification and referral of youth in need of mental health services. The KSADS-Bridge assessment tool with its RDoC neurocognitive tasks, when completed with the self- or clinician administered KSADS-COMP, will help to create cross-talk between the DSM and RDoC diagnostic perspectives, and begin to generate a database on the relationship between RDoC constructs and treatment outcomes across a range of diagnostic categories.

Psychiatric Disorder

Center for Psychological Consultation223 participantsStarted Sep 2016

Baltimore, Maryland, United States • Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 1< 1 mile

Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies

NCT02383212

This is a phase 1, open-label, multicenter, ascending-dose escalation study of cemiplimab, alone and in combination with other anti-cancer therapies in patients with advanced malignancies.

Advanced CancerAdvanced Malignancies

Regeneron Pharmaceuticals398 participantsStarted Feb 2015

Gilbert, Arizona, United States • Goodyear, Arizona, United States • Phoenix, Arizona, United States +44 more locations

Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders

Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies

Find Trials by Condition in Pittsburgh

Vitamin D to Improve Outcomes by Leveraging Early Treatment

Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers

Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair

A Study of Siltuximab (Anti- IL 6 Monoclonal Antibody) in Patients With High-risk Smoldering Multiple Myeloma

Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women

Dasotraline Pediatric Extension Study

Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study

Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia

Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors

Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics

SVRII Family Factors Study

Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)

A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

First in Patient Study for PF-06840003 in Malignant Gliomas

Scalp Application of LED Therapy to Improve Thinking and Memory in Veterans With Gulf War Illness

Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma